Clinical Trial Update: Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study investigating higher-dose weekly topotecan in patients with extensive-stage small-cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Small Cell Lung Cancer, Carcinoma, Small Cell | Phase 2 | Status: COMPLETED